Red blood cell width and blood sugar in type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study looks at two blood test results—HbA1c (average blood sugar) and red blood cell width (RDW)—in people with type 2 diabetes whose blood sugar is not well controlled. The goal is to see how these two measurements relate after improving blood sugar management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 2 diabetes.
- Your blood sugar is not well controlled, meaning your HbA1c is over 7%.
- You do not have type 1 diabetes or diabetes caused by another medical condition.
- You are not anemic (low red blood cells), pregnant, or have inflammatory bowel disease.
- You have not had a blood transfusion recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses math models to understand how your blood sugar and hormones respond to food and insulin. You'll eat study foods and provide blood samples so researchers can better predict how your body handles diabetes.
This study looks at differences in body fat to understand why some people develop type 2 diabetes. You may be asked for blood tests and health information to see if your diabetes risk and body fat patterns are linked.
This study looks at how platelets (the cells that help your blood clot) change in people with type 2 diabetes. It may help doctors understand diabetes better and find new ways to manage it.
This study measures immune cells from your blood to find markers (biomarkers) that may explain or predict diabetic cardiomyopathy, a type of heart condition linked to diabetes. You may benefit mainly by being closely monitored and contributing to research that could improve future diagnosis or risk tracking.
This trial looks at fat stored around the heart in people with type 2 diabetes, using samples already collected from a larger study. Researchers want to understand how this fat relates to diabetes, but it does not test any new drug or treatment.
This study looks at how certain blood cell ratios relate to blood sugar control and blood vessel problems in people with type 2 diabetes. It helps doctors understand which patients might be at higher risk for complications.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.